Articles

Supportive Care in the Oncology Setting
There are numerous complications that may develop in patients with cancer; some are related to the disease itself, whereas others are associated with agents or combination regimens used during the course of treatment. Read More ›

The Role of the Oncology Nurse Navigator in Improving Supportive Care
A nurse/patient navigator is defined by the Academy of Oncology Nurse & Patient Navigators as “a medical professional whose clinical expertise and training guides patients and their caregivers to make informed decisions, collaborating with a multidisciplinary team to allow for timely cancer screening, diagnosis, treatment, and increased supportive care across the cancer continuum.” Read More ›

The US Food and Drug Administration (FDA) granted accelerated approval for Keytruda (pembrolizumab) to treat patients with advanced (metastatic) non–small-cell lung cancer (NSCLC) whose disease has progressed after other treatments, and with tumors that express a protein called PD-L1. Read More ›

On September 30, 2015, the US Food and Drug Administration (FDA) granted accelerated approval to nivolumab (Opdivo Injection, Bristol-Myers Squibb Company) in combination with ipilimumab for the treatment of patients with BRAF V600 wild-type, unresectable or metastatic melanoma. Read More ›

Noteworthy Numbers: October Is Breast Cancer Awareness Month
Since its beginnings in 1985, the movement to raise breast cancer awareness has consistently gathered momentum. Read More ›

Highlights from the 2015 Annual Meeting of the American Society of Clinical Oncology
The Annual Meeting of the American Society of Clinical Oncology (ASCO) is the largest and most important oncology specialty meeting in the United States, and arguably the world. More than 30,000 oncology professionals gathered in Chicago, IL, to hear about ground-breaking research, state-of-the-art treatment modalities, new therapies, and ongoing controversies in the field. Read More ›

The Perceptual Gap in the Impact of Chemotherapy- and Radiotherapy-Induced Nausea and Vomiting
The severity and impact of nausea and vomiting (NV) on patients undergoing chemotherapy and radiotherapy is greater than estimated by oncology physicians and nurses, according to research presented by Cheryl Vidall at the 2015 Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology International Symposium on Supportive Care in Cancer. Read More ›

Considerations for Young Adults with Cancer
Young adults (YA) with cancer are a unique population with special needs. Nurses can play an important role in addressing the psychosocial needs, as well as the physical needs, of this population. Read More ›

Billings Clinic Cancer Center
The Billings Clinic Cancer Center in Montana offers expert multidisciplinary care for patients with cancer. The center’s team approach to care includes physician and nurse specialists in oncology/hematology, patient care navigators, counselors and social workers, dietitians, a genetic counselor, and a naturopathic physician. Read More ›

Vaccines are also being studied in melanoma and other cancers. These vaccines are engineered to educate the immune system. Read More ›

Page 211 of 376


Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive: